COVID-19 has rapidly spread all over the world, progressing into a pandemic. This situation has urgently impelled many companies and public research institutes to concentrate their efforts on research for effective therapeutics. Here, we outline the strategies and targets currently adopted in developing a vaccine against SARS-CoV-2. Based on previous evidence and experience with SARS and MERS, the primary focus has been the Spike protein, considered as the ideal target for COVID-19 immunotherapies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268185 | PMC |
| http://dx.doi.org/10.1186/s12967-020-02392-y | DOI Listing |
Publication Analysis
Top Keywords
spike protein
8
sars-cov-2 spike
4
protein optimal
4
optimal immunological
4
immunological target
4
target vaccines
4
vaccines covid-19
4
covid-19 rapidly
4
rapidly spread
4
spread progressing
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!